APA (7th ed.) Citation

McLaughlin, M. G., Stone, G. W., Aymong, E., Gardner, G., Mehran, R., Lansky, A. J., . . . Zimetbaum, P. (2004). Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Journal of the American College of Cardiology, 44(6), 1215. https://doi.org/10.1016/j.jacc.2004.06.053

Chicago Style (17th ed.) Citation

McLaughlin, Michael G., et al. "Prognostic Utility of Comparative Methods for Assessment of ST-segment Resolution After Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial." Journal of the American College of Cardiology 44, no. 6 (2004): 1215. https://doi.org/10.1016/j.jacc.2004.06.053.

MLA (9th ed.) Citation

McLaughlin, Michael G., et al. "Prognostic Utility of Comparative Methods for Assessment of ST-segment Resolution After Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial." Journal of the American College of Cardiology, vol. 44, no. 6, 2004, p. 1215, https://doi.org/10.1016/j.jacc.2004.06.053.